Strategic role of selected noble metal nanoparticles in medicine

Critical Reviews in Microbiology

Volumn 42, Issue 5, 2016, Pages 696-719

  Rai, Mahendra ^a   Ingle, Avinash P ^a   Birla, Sonal ^a   Yadav, Alka ^a   Santos, Carolina Alves Dos ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cancer; diagnosis; HIV; nanoparticles; noble metals; sensors; treatment; tuberculosis

Indexed keywords

GOLD NANOPARTICLE; METAL NANOPARTICLE; NANOCARRIER; PLATINUM NANOPARTICLE; REACTIVE OXYGEN METABOLITE; SILVER NANOPARTICLE; VACCINE; GOLD; PLATINUM; SILVER;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; BACTERIAL INFECTION; BACTERIUM; BONE ALLOGRAFT; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CYTOTOXICITY; DENTISTRY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NANOMEDICINE; NANOPHARMACEUTICS; NANOTECHNOLOGY; NANOTOXICOLOGY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS; VIRUS INFECTION; ANIMAL; CHEMISTRY; DEVICES; DRUG DELIVERY SYSTEM; DRUG THERAPY; MEDICINE; PROCEDURES;

ANIMALS; DRUG DELIVERY SYSTEMS; DRUG THERAPY; GOLD; HUMANS; MEDICINE; METAL NANOPARTICLES; PLATINUM; SILVER;

EID: 84979497781     PISSN: 1040841X     EISSN: 15497828     Source Type: Journal    
DOI: 10.3109/1040841X.2015.1018131     Document Type: Review

References (214)

1. S.Ahn, I.H.Lee, S.Kang,. (2014). Gold nanoparticles displaying tumor-associated self-antigens as a potential vaccine for cancer immunotherapy. Adv Healthcare Mater 3:1194–99
2. A.Alanis. (2005). Resistance to antibiotics: are in the post-antibiotic era? Arch Med Res 36:697–705
3. M.K.R.Ali, S.R.Panikkanvalappil, M.A.El-Sayed. (2014). Enhancing the efficiency of gold nanoparticles treatment of cancer by increasing their rate of endocytosis and cell accumulation using rifampicin. J Am Chem Soc 136:4464–7
4. J.P.M.Almeida, A.Y.Lin, E.R.Figueroa,. (2014). In vivo gold nanoparticle delivery of peptide vaccine induces anti-tumor immune response in prophylactic and therapeutic tumor models. Small 11:1453–59
5. C.Alric, J.Taleb, G.Le Duc,. (2008). Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging. J Am Chem Soc 130:5908–15
6. R.K.Ambasta, A.Sharma, P.Kumar. (2011). Nanoparticle mediated targeting of VEGFR and cancer stem cells for cancer therapy. Vascular Cell 3:26, doi: 10.1186/2045-824X-3-26
7. American Cancer Society, Cancer facts and figures 2013. Atlanta: American Cancer Society, 2013, 1–60
8. B.Arnaiz, O.Martinez-Avila, J.M.Falcon-Perez, S.Penades. (2012). Cellular uptake of gold nanoparticles bearing HIV gp120 oligomannosides. Bioconjug Chem 23:814–25
9. R.R.Arvizo, S.Bhattacharyya, R.A.Kudgus,. (2012). Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chem Soc Rev 41:2943–70
10. P.Asharani, Y.L.Wu, Z.Gong, S.Valiyaveettil. (2008). Toxicity of silver nanoparticles in zebrafish models. Nanotechnology 19:255102
11. P.V.Asharani, Y.Lianwu, Z.Gong, S.Valiyaveettil. (2011). Comparison of the toxicity of silver, gold and platinum nanoparticles in developing zebrafish embryos. Nanotoxicology 5:43–54
12. P.V.Asharani, N.G.Xinyi, P.M.Hande, S.Valiyaveettil. (2010). DNA damage and p53-mediated growth arrest in human cells treated with platinum nanoparticles. Nanomedicine 5:51–64
13. M.G.B.Ashiq, M.A.Saeed, B.A.Tahir,. (2013). Breast cancer therapy by laser-induced Coulomb explosion of gold nanoparticles. Chin J Cancer Res 25:756–61
14. L.A.Austin, B.Kang, C.W.Yen,. (2011). Nuclear targeted silver nanospheres perturb the cancer cell cycle differently than those of nanogold. Bioconjug Chem 22:2324–31
15. M.I.Badawi, M.M.Ahmed. (2014). Gold nanoparticles as high-resolution imaging contrast agents for early cancer diagnoses: computational study. Int J Chem Appl Biol Sci 1:12–17
16. P.V.Baptista, M.Koziol-Montewka, J.Paluch-Oles,. (2006). Gold-nanoparticle-probe-based assay for rapid and direct detection of Mycobacterium tuberculosis DNA in clinical samples. Clin Chem 52:1433–4
17. A.R.Bastian, A.Nangarlia, L.D.Bailey,. (2014). Mechanism of multivalent nanoparticle encounter with HIV-1 for potency enhancement of peptide triazole virus inactivation. J Biol Chem 290:529–43
18. C.C.Berry, J.M.de la Fuente, M.Mullin,. (2007). Nuclear localization of HIV-1 Tat functionalized gold nanoparticles. IEEE Trans Nanobiosci 6:262–9
19. S.H.Bloch, M.Wan, P.A.Dayton, K.W.Ferrara. (2004). Optical observation of lipid-and polymer-shelled ultrasound microbubble contrast agents. Appl Phys Lett 84:631–3
20. M.C.Bowman, T.E.Ballard, C.J.Ackerson,. (2008). Inhibition of HIV fusion with multivalent gold nanoparticles. J Am Chem Soc 130:6896–7
21. A.N.Brown, K.Smith, T.A.Samuels,. (2012). Nanoparticles functionalized with ampicillin destroy multiple-antibiotic-resistant isolates of Pseudomonas aeruginosa and Enterobacter aerogenes and methicillin-resistant Staphylococcus aureus. Appl Environ Microbiol 78:2768–74
22. A.Bruckbauer, D.Klenerman. (2004). An addressable antibody nanoarray produced on a nanostructured surface. J Am Chem Soc 126:6508–9
23. R.Cao-Milan, L.M.Liz-Marzan. (2014). Gold nanoparticle conjugates: recent advances toward clinical applications. Expert Opin Drug Deliv 11:741–52
24. M.Y.Chang, A.L.Shiau, Y.H.Chen,. (2008). Increased apoptotic potential and dose-enhancing effect of gold nanoparticles in combination with single-dose clinical electron beams on tumor-bearing mice. Cancer Sci 99:1479–84
25. K.K.Chatterjee. (2007). Use of metals and metallic minerals. New Delhi, India: New Age International (P) Limited
26. H.Chen, X.Kou, Z.Yang,. (2008). Shape-and size-dependent refractive index sensitivity of gold nanoparticles. Langmuir 24:5233–7
27. L.C.Chen, C.W.Wei, J.S.Souris,. (2010). Enhanced photoacoustic stability of gold nanorods by silica matrix confinement. J Biomed Opt 15:016010
28. N.Chen, Y.Zheng, J.Yin,. (2013). Inhibitory effects of silver nanoparticles against adenovirus type 3 in vitro. J Virol Methods 193:470–7
29. Y.S.Chen, Y.C.Hung, W.H.Lin, G.S.Huang. (2010b). Assessment of gold nanoparticles as a size-dependent vaccine carrier for enhancing the antibody response against synthetic foot-and-mouth disease virus peptide. Nanotechnology 21:195101
30. Y.Cheng, L.Yin, S.Lin,. (2011). Toxicity reduction of polymer-stabilized silver nanoparticles by sunlight. J Phys Chem C 115:4425–32
31. F.Chiodo, M.Marradi, J.Calvo,. (2014). Glycosystems in nanotechnology: gold glyconanoparticles as carrier for anti-HIV prodrugs. Beilstein J Org Chem 10:1339–46
32. A.O.Choi, S.J.Cho, J.Desbarats,. (2007). Quantum dot-induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cells. J Nanobiotechnol 5:1, doi: 10.1186/1477-3155-5-1
33. Y.E.Choi, J.W.Kwak, J.W.Park. (2010). Nanotechnology for early cancer detection. Sensors 10:428–55
34. T.Coccini, R.Gornati, F.Rossi,. (2014). Gene expression changes in rat liver and testes after lung instillation of a low dose of silver nanoparticles. J Nanomed Nanotechnol 5:227. doi: 10.4172/2157-7439.1000227
35. C.Coman, F.Tabaran, I.Ilie,. (2013). Assessment of silver nanoparticles toxicity in human red blood cells using ELISA and immunofluorescence microscopy techniques. Biotechnol Mol Biol Nanomed 1:61–5
36. J.Conde, G.aloDoria, P.Baptista. (2012). Noble metal nanoparticles applications in cancer. J Drug Del, Article ID 751075 (12 pages)
37. R.Coradeghini, S.Gioria, C.P.García,. (2013). Size-dependent toxicity and cell interaction mechanisms of gold nanoparticles on mouse fibroblasts. Toxicol Lett 217:205–16
38. P.Costa, A.Amaro, A.Botelho,. (2010). Gold nanoprobe assay for the identification of mycobacteria of the Mycobacterium tuberculosis complex. Clin Microbiol Infect 16:1464–9
39. J.A.Coulter, W.B.Hyland, J.Nicol, F.J.Currell. (2013). Radio sensitising nanoparticles as novel cancer therapeutics: pipe dream or realistic prospect? Clin Oncol 25:593–603
40. P.J.Debouttiere, S.Roux, F.Vocanson,. (2006). Design of gold nanoparticles for magnetic resonance imaging. Adv Fun Mater 16:2330–9
41. S.Dominguez-Medina, J.Blankenburg, J.Olson,. (2013). Adsorption of a protein monolayer via hydrophobic interactions prevents nanoparticle aggregation under harsh environmental conditions. ACS Sustain Chem Eng 1:833–42
42. G.Doria, J.Conde, B.Veigas,. (2012). Noble metal nanoparticles for biosensing applications. Sensors 12:1657–87
43. D.C.Douek, M.Roederer, R.A.Koup. (2009). Emerging concepts in the immuno-pathogenesis of AIDS. Annu Rev Med 60:471–784
44. M.Duman, M.O.Caglayan, G.Demirel, E.Piskin. (2009). Detection of Mycobacterium tuberculosis complex using surface plasmon resonance based sensors carrying self-assembled nano-overlayers of probe oligonucleotide. Sensor Lett 7:535–42
45. K.Eid, A.Eldesouky, A.Fahmy,. (2013). Calcium phosphate scaffold loaded with platinum nanoparticles for bone allograft. Am J Biomed Sci 5:242–9
46. J.L.Elechiguerra, J.L.Burt, J.R.Morones,. (2005). Interaction of silver nanoparticles with HIV. J Nanobiotecnhol 3:1–10
47. M.A.El-Sayed. (2001). Some interesting properties of metals confined in time and nanometer space of different shapes. Acc Chem Res 34:257–64
48. S.M.El-Sonbaty. (2013). Fungus-mediated synthesis of silver nanoparticles and evaluation of antitumor activity. Cancer Nano 4:73–9
49. M.Essig, J.Debus, H.P.Schlemmer,. (2000). Improved tumor contrast and delineation in the stereotactic radiotherapy planning of cerebral gliomas and metastases with contrast media supported FLAIR imaging. Strahlenther Onkol 176:84–94
50. D.R.Fatemeh, H.EbrahimiShahmabadi, A.Abedi,. (2014). Polybutylcyanoacrylate nanoparticles and drugs of the platinum family: last status. Indian J Clin Biochem 29:333–8
51. M.Ferrari. (2005). Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5:161–71
52. R.Foldbjerg, D.A.Dang, H.Autrup. (2011). Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol 85:743–50
53. Y.Fujita, H.Taguchi. (2011). Current status of multiple antigen-presenting peptide vaccine systems: application of organic and inorganic nanoparticles. Chem Central J 5:48, doi:10.1186/1752-153X-5-48
54. S.Gaikwad, A.Ingle, A.Gade,. (2013). Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3. Int J Nanomed 8:4303–14
55. M.Gajendiran, S.M.J.Yousuf, V.Elangovan, S.Balasubramanian. (2014). Gold nanoparticle conjugated PLGA-PEG-SA-PEG-PLGA multiblock copolymer nanoparticles: synthesis, characterization, in vivo release of rifampicin. J Mater Chem B2:418–27
56. M.Gielen, E.R.T.Tiekink. (2005). Metallotherapeutic drugs and metal-based diagnostic agents: the use of metals in medicine. Chichester: John Wiley and Sons
57. A.R.Gliga, S.Skoglund, I.O.Wallinder,. (2014). Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release. Part Fiber Toxicol 11:11
58. J.Gopal, N.Hasan, M.Manikandan, H.Wu. (2013). Bacterial toxicity/compatibility of platinum nanospheres, nanocuboids and nanoflowers. Sci Rep 3:1260, doi: 10.1038/srep01260
59. A.E.Gregory, R.Titball, D.Williamson. (2013). Vaccine delivery using nanoparticles. Front Cell Infect Microbiol 3:13, doi: 10.3389/fcimb.2013.00013
60. P.Grodzinski, M.Silver, L.K.Molnar. (2006). Nanotechnology for cancer diagnostics: promises and challenges. Expert Rev Mol Diagn 6:307–18
61. D.Guo, L.Zhu, Z.Huang,. (2013). Anti-leukemia activity of PVP-coated silver nanoparticles via generation of reactive oxygen species and release of silver ions. Biomaterials 34:7884–94
62. A.K.Gupta, M.Gupta. (2005). Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26:3995–4021
63. I.Gupta, N.Duran, M.Rai. (2012). Nano-silver toxicity: Emerging concerns and consequences in human health. In: M.Rai, N.Cioffi, eds. Nano-antimicrobials: progress and prospects. Germany: Springer Verlag, 525–48
64. S.Gurunathan, J.W.Han, A.A.Dayem,. (2013a). Green synthesis of anisotropic silver nanoparticles and its potential cytotoxicity in human breast cancer cells (MCF-7). J Ind Eng Chem 19:1600–5
65. S.Gurunathan, J.W.Han, V.Eppakayala,. (2013b). Cytotoxicity of biologically synthesized silver nanoparticles in MDA-MB-231 human breast cancer cells. BioMed Res Int 2013:535796. doi: 10.1155/2013/535796
66. S.Gurunathan, J.Raman, S.N.Abd Malek,. (2013c). Green synthesis of silver nanoparticles using Ganoderma neo-japonicum Imazeki: a potential cytotoxic agent against breast cancer cells. Int J Nanomed 8:4399–413
67. N.Haberl, S.Hirn, A.Wenk,. (2013). Cytotoxic and proinflammatory effects of PVP-coated silver nanoparticles after intratracheal instillation in rats. Beilstein J Nanotech 4:933–40
68. J.F.Hainfeld, F.A.Dilmanian, Z.Zhong,. (2010). Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma. Phys Med Biol 55:3045–59
69. J.F.Hainfeld, D.N.Slatkin, T.M.Focella, H.M.Smilowitz. (2006). Gold nanoparticles: a new X-ray contrast agent. Braz J Radiol 79:248–53
70. J.F.Hainfeld, D.N.Slatkin, H.M.Smilowitz. (2004). The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol 49:N309–15
71. J.W.Han, S.Gurunathan, J.K.Jeong,. (2014). Oxidative stress mediated cytotoxicity of biologically synthesized silver nanoparticles in human lung epithelial adenocarcinoma cell line. Nanoscale Res Lett 9:459, doi: 10.1186/1556-276X-9-459
72. M.G.Harisinghani, J.Barentsz, P.F.Hahn,. (2003). Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. J Med 348:2491–9
73. Q.He, Z.Zhu, L.Jin,. (2014). Detection of HIV-1 p24 antigen using streptavidin-biotin and gold nanoparticles based immunoassay by inductively coupled plasma mass spectrometry. J Anal At Spectrom 29:1477–82
74. W.He, Y.T.Zhou, W.G.Wamer,. (2012). Mechanisms of the pH dependent generation of hydroxyl radicals and oxygen induced by Ag nanoparticles. Biomaterials 33:7547–55
75. J.R.Heath, M.E.Davis. (2008). Nanotechnology and cancer. Annu Rev Med 59:251–65
76. K.Hikosaka, J.Kim, M.Kajita,. (2008). Platinum nanoparticles have an activity similar to mitochondrial NADH: ubiquinone oxidoreductase. Colloid Surf B: Biointerfaces 66:195–200
77. L.R.Hirsch, R.J.Stafford, J.A.Bankson,. (2003). Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Nat Acad Sci USA 100:13549–54
78. S.Hoshika, F.Nagano, T.Tanaka,. (2010). Effect of application time of colloidal PtNPs on the microtensile bond strength to dentin. Dental Mater J 29:682–9
79. J.L.Hou, G.Shuo, L.Grozova. (2013). Reduction of silver nanoparticle toxicity by sulphide. Adv Mater Lett 4:131–3
80. R.L.Hu, S.R.Li, F.J.Kong,. (2014). Inhibition effect of silver nanoparticles on herpes simplex virus 2. Genet Mol Res 13:7022–8
81. Z.Huaizhi, N.Yuantao. (2001). China’s ancient gold drugs. Gold Bull 34:24–9
82. X.Huang, P.K.Jain, I.H.El-Sayed, M.A.El-Sayed. (2007). Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine 2:681–93
83. A.J.Huh, Y.J.Kwon. (2011). Nanoantibiotics: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release 156:128–45
84. S.Huo, H.Ma, K.Huang,. (2012). Superior penetration and retention behavior of 50 nm gold nanoparticles in tumors. Cancer Res 73:319–30
85. M.M.Hussain, T.M.Samir, H.M.Azzazy. (2013). Unmodified gold nanoparticles for direct and rapid detection of Mycobacterium tuberculosis complex. Clin Biochem 46:633–7
86. S.Hwang, J.Nam, J.Song,. (2014). A sub 6 nanometer plasmonic gold nanoparticle for pH-responsive near-infrared photothermal cancer therapy. New J Chem 38:918–22
87. D.Irvine, L.Vincent, J.E.Graydon,. (1994). The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. Cancer Nurs 17:367–78
88. G.A.Jacoby, L.S.M.Price. (2005). The new beta-lactamases. New Eng J Med 352:380–91
89. P.K.Jain, K.S.Lee, I.H.El-Sayed, M.A.El-Sayed. (2006). Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. J Phys Chem B110:7238–48
90. M.Jeyaraj, M.Rajesh, R.Arun,. (2013a). An investigation on the cytotoxicity and caspase-mediated apoptotic effect of biologically synthesized silver nanoparticles using Podophyllum hexandrum on human cervical carcinoma cells. Colloid Surf B: Biointerfaces 102:708–17
91. M.Jeyaraj, G.Sathishkumar, G.Sivanandhan,. (2013b). Biogenic silver nanoparticles for cancer treatment: an experimental report. Colloids Surf B: Biointerfaces 106:86–92
92. A.K.Jha, K.Prasad. (2014). Green synthesis of silver nanoparticles and its activity on SiHa cervical cancer cell line. Adv Mat Lett 5:501–05
93. W.Jiang, B.Y.Kim, J.T.Rutka, W.C.Chan. (2008). Nanoparticle mediated cellular response is size-dependent. Nat Nanotechnol 3:145–50
94. R.Johnson, N.Sabnis, W.J.McConathy, A.G.Lacko. (2013). The potential role of nanotechnology in therapeutic approaches for triple negative breast cancer. Pharmaceutics 5:353–70
95. H.J.Johnston, G.Hutchison, F.M.Christensen,. (2010). A review of the in vivo and in vitro toxicity of silver and gold particulates: particle attributes and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol 40:328–46
96. T.Kaewphinit, S.Santiwatanakul, K.Chansiri. (2012). Gold nanoparticle amplification combined with quartz crystal microbalance DNA based biosensor for detection of Mycobacterium tuberculosis. Sensors Trans J 146:156–63
97. J.C.Y.Kah, K.W.Kho, C.G.L.Lee,. (2007). Early diagnosis of oral cancer based on the surface plasmon resonance of gold nanoparticles. Int J Nanomed 2:785–98
98. P.Kanmani, S.T.Lim. (2013). Synthesis and structural characterization of silver nanoparticles using bacterial exopolysaccharide and its antimicrobial activity against food and multidrug resistant pathogens. Process Biochem 48:1099–106
99. R.Kesarkar, G.Oza, S.Pandey,. (2012). Gold nanoparticles: effective as both entry inhibitors and virus neutralizing agents against HIV. J Microbiol Biotech Res 2:276–83
100. T.Khushnud, S.A.Mousa. (2013). Potential role of naturally derived polyphenols and their nanotechnology delivery in cancer. Mol Biotechnol 55:78–86
101. S.Kim, J.E.Choi, J.Cho,. (2009). Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol In Vitro 23:1076–84
102. Y.S.Kim, J.S.Kim, H.S.Cho,. (2008). Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague–Dawley rats. Inhal Toxicol 20:575–83
103. W.Kim, J.Kim, H.Park,. (2012). Platinum nanoparticles reduce ovariectomy-induced bone loss by decreasing osteoclastogenesis. Exp Mol Med 44:432–9
104. M.S.Kim, M.A.Woo, Y.Ye,. (2014). Highly efficient colorimetric detection of target cancer cells utilizing superior catalytic activity of graphene oxide–magnetic-platinum nanohybrids. Nanoscale 6:1529–36
105. K.T.Kim, T.Zaikova, J.E.Hutchison, R.L.Tanguay. (2013). Gold nanoparticles disrupt zebrafish eye development and pigmentation. Toxicol Sci 133:275–88
106. T.Kong, J.Zeng, X.Wang,. (2008). Enhancement of radiation cytotoxicity in breast-cancer cells by localized attachment of gold nanoparticles. Small 4:1537–43
107. P.Konieczny, A.G.Goralczyk, R.Szmyd,. (2013). Effects triggered by platinum nanoparticles on primary keratinocytes. Int J Nanomed 8:3963–75
108. Kumar A, Boruah BM, Lian XJ. (2011). Gold nanoparticles: promising nanomaterials for the diagnosis of cancer and HIV/AIDS. J Nanomater 2011, Article ID 202187 (17 pages)
109. H.H.Lara, N.V.Ayala-Nunez, L.D.C.Ixtepan-Turrent, C.Padilha-Rodrigues. (2010a). Mode of antiviral action of silver nanoparticles against HIV. J Nanobiotecnhol 8: 1 (10 pages)
110. H.H.Lara, N.V.Ayala-Nunez, L.D.C.Ixtepan-Turrent, C.Padilha-Rodrigues. (2010b). Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria. World J Microbiol Biotechnol 26:615–21
111. H.H.Lara, N.V.Ayala-Nunez, L.D.C.Ixtepan-Turrent, C.Padilha-Rodrigues. (2010c). PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture. J Nanobiotecnhol 8:1–11
112. H.H.Lara, L.Ixtepan-Turrent, E.G.Trevino, D.Singh. (2011). Use of silver nanoparticles increased inhibition of cell-associated HIV-1 infection by neutralizing antibodies developed against HIV-1 envelope proteins. J Nanobiotechnol 9:38, doi: 10.1186/1477-3155-9-38
113. J.H.Lara-González, R.Gomez-Flores, P.Tamez-Guerra,. (2013). In vivo antitumor activity of metal silver and silver nanoparticles in the L5178Y-R murine lymphoma model. Br J Med Med Res 3:1308–16
114. I.H.Lee, H.K.Kwon, S.An,. (2012). Imageable antigen-presenting gold nanoparticle vaccines for effective cancer immunotherapy in vivo. Angew Chem, Int Ed 51:8800–5
115. W.Lee, J.K.Kim, D.G.Lee. (2014). A novel mechanism for the antibacterial effect of silver nanoparticles on Escherichia coli. Biometals 27:1191–201
116. L.H.Li, M.Y.Yen, C.C.Ho,. (2013). Non-cytotoxic nanomaterials enhance antimicrobial activities of cefmetazole against multidrug-resistant Neisseria gonorrhoeae. PLoS One 8:e64794
117. Y.Li, Z.Tang, P.N.Prasad,. (2014). Peptide-mediated synthesis of gold nanoparticles: effects of peptide sequence and nature of binding on physicochemical properties. Nanoscale 6:3165–72
118. Z.B.Li, W.Cai, X.Chen. (2007). Semiconductor quantum dots for in vivo imaging. J Nanosci Nanotechnol 7:2567–81
119. J.Lin, Y.Zhang, J.Qian, S.He. (2014). A nano-plasmonic chip for simultaneous sensing with dual-resonance surface-enhanced Raman scattering and localized surface plasmon resonance. Laser Photo Rev 8:610–16
120. C.Liu, D.Jiang, G.Xiang,. (2014). An electrochemical DNA biosensor for the detection of Mycobacterium tuberculosis, based on signal amplification of graphene and a gold nanoparticle-polyaniline nanocomposite. Analyst 139:5460–5
121. C.J.Liu, C.H.Wang, S.T.Chen,. (2010). Enhancement of cell radiation sensitivity by pegylated gold nanoparticles. Phys Med Biol 55:931–45
122. J.Liu, Y.Zhao, Q.Guo,. (2012). TAT-modified nanosilver for combating multidrug-resistant cancer. Biomaterials 33:6155–61
123. N.V.Long, N.D.Chien, T.Hayakawa,. (2010). The synthesis and characterization of nanoparticles. Nanotechnology 21:035605
124. R.Ma, Z.Wang, L.Yan,. (2014). Novel Pt-loaded layered double hydroxide nanoparticles for efficient and cancer-cell specific delivery of a cisplatin prodrug. J Mater Chem B2:4868–75
125. A.Madhusudhan, G.B.Reddy, M.Venkatesham,. (2014). Efficient pH dependent drug delivery to target cancer cells by gold nanoparticles capped with carboxymethyl chitosan. Int J Mol Sci 15:8216–34
126. S.A.Maier, P.G.Kik, H.A.Atwater,. (2003). In metal nanoparticle plasmon waveguides. Nat Mater 2:229–32
127. S.Malathi, M.D.Balakumaran, P.T.Kalaichelvann, S.Balasubramanian. (2013). Green synthesis of gold nanoparticles for controlled delivery. Adv Mater Lett 4:933–40
128. M.F.McLaughlin, J.Woodward, R.A.Boll,. (2013). Gold coated lanthanide phosphate nanoparticles for targeted alpha generator radiotherapy. PLoS One 8:e54531
129. M.P.Melancon, W.Lu, C.Li. (2009). Gold-based magneto/optical nanostructures: challenges for in vivo applications in cancer diagnostics and therapy. Mater Res Bull 34:415–21
130. A.Mesbahi. (2010). A review on gold nanoparticles radiosensitization effect in radiation therapy of cancer. Rep Pract Oncol Radiother 15:176–80
131. I.Mfouo-Tynga, A.Hussein, M.Abdel-Harith, H.Abrahamse. (2014). Photodynamic ability of silver nanoparticles in inducing cytotoxic effects in breast and lung cancer cell lines. Int J Nanomed 9:3771–80
132. H.Mohammadi, A.Abedi, A.Akbarzadeh,. (2013). Evaluation of synthesized platinum nanoparticles on the MCF-7 and HepG-2 cancer cell lines. Int Nano Lett 3:28–32
133. A.J.Moreira, S.Lopera, N.Ordonez, R.D.Mansano. (2012). Platinum nanoparticles deposition on polymeric membranes for fuel cell applications. J Phys: Conf Ser 370:1–12
134. Y.Mori, T.Ono, Y.Miyahira,. (2013). Antiviral activity of silver nanoparticle/chitosan composites against H1N1 influenza A virus. Nanoscale Res Lett 8:93, doi: 10.1186/1556-276X-8-93
135. J.R.Morones, J.L.Elechiguerra, A.Camacho,. (2005). The bactericidal effect of silver nanoparticles. Nanotechnology 16:2346–53
136. J.R.Morones-Ramirez, J.A.Winkler, C.S.Spina, J.J.Collins. (2013). Silver enhances antibiotic activity against Gram negative bacteria. Sci Transl Med 5:190ra81
137. L.A.Nagahara, M.Ferrari, P.Grodzinski. (2009). Nanofunctional materials in cancer research: challenges, novel methods, and emerging applications. Mater Res Bull 34:406–14
138. A.Nagy, A.Harrison, S.Sabbani,. (2011). Silver nanoparticles embedded in zeolite membranes: release of silver ions and mechanism of antibacterial action. Int J Nanomed 6:1833–52
139. S.Z.Naqvi, U.Kiran, M.Ali,. (2013). Combined efficacy of biologically synthesized silver nanoparticles and different antibiotics against multidrug-resistant bacteria. Int J Nanomed 8:3187–95
140. J.Nellore, C.Pauline, K.Amarnath, J.Neurodegen. (2013). Bacopa monnieri phytochemicals mediated synthesis of platinum nanoparticles and its neurorescue effect on 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced experimental Parkinsonism in zebrafish. J Neurodegener Dis 2013: Article ID 972391, 8 pages
141. J.E.Newton, J.A.Preece, B.G.Pollet. (2012). Control of nanoparticle aggregation in PEMFCs using surfactants. Int J Low-Carbon Tech 7:38–43
142. K.M.Newton, H.L.Puppala, C.L.Kitchens,. (2013). Silver nanoparticle toxicity to Daphnia magna is a function of dissolved silver concentration. Environ Toxicol Chem 32:2356–64
143. V.Q.Nguyen, M.Ishihara, Y.Mori,. (2013). Preparation of size-controlled silver nanoparticles and chitin-based composites and their antimicrobial activities. J Nanomater 2013:693486
144. T.Niidome, M.Yamagata, Y.Okamoto,. (2006). PEG-modified gold nanorods with a stealth character for in vivo applications. J Control Release 114:343–7
145. E.Oberdörster. (2004). Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile Largemouth Bass. Environ Health Perspect 112:1058–62
146. L.Obreja, D.Pricop, N.Foca, V.Melnig. (2008). Alcoholic reduction platinum nanoparticles synthesis by sonochemical method. Mater Plast 47:42–7
147. Y.Oni, K.Hao, S.Dozie-Nwachukwu,. (2014). Gold nanoparticles for cancer detection and treatment: the role of adhesion. J Appl Phys 115:084305 (8 pages)
148. D.Pal, C.K.Sahu, A.Haldar. (2014). The ancient Indian nanomedicine. J Adv Pharm Technol Res 5:4–12
149. S.Pal, Y.K.Tak, J.M.Song. (2007). Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticles, a study of the Gram negative bacterium. Appl Environ Microbiol 73:1721–0
150. Y.Pan, S.Neuss, A.Leifert,. (2007). Size-dependent cytotoxicity of gold nanoparticles. Small 3:1941–9
151. K.K.Panda, V.M.M.Achary, R.Krishnaveni,. (2011). In vitro biosynthesis and genotoxicity bioassay of silver nanoparticles using plants. Toxicol In Vitro 25:1097–105
152. E.Park, E.Bae, J.Yi,. (2010a). Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environ Toxicol Pharmacol 30:162–8
153. E.J.Park, J.Yi, Y.Kim,. (2010b). Silver nanoparticles induce cytotoxicity by a Trojan-horse type mechanism. Toxicol In Vitro 24:872–8
154. Y.M.Park, S.J.Lee, Y.S.Kim,. (2013). Nanoparticle-based vaccine delivery for cancer immunotherapy. Immune Netw 13:177–83
155. C.R.Patra, R.Bhattacharya, D.Mukhopadhyay, P.Mukherjee. (2010). Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv Drug Deliv Rev 62:346–61
156. C.R.Patra, R.Bhattacharya, E.Wang,. (2008). Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Cancer Res 68:1970–8
157. R.Y.Pelgrift, A.J.Friedman. (2013). Nanotechnology as a therapeutic tool to combat microbial resistance. Adv Drug Deliv Rev 65:1803–15
158. H.Peng, X.Zhang, Y.Wei,. (2012). Cytotoxicity of silver nanoparticles in human embryonic stem cell-derived fibroblasts and an L-929 cell line. J Nanomater 2012: Article ID 160145, 9 pages
159. N.A.Peppas. (2004). Intelligent therapeutics: biomimetic systems and nanotechnology in drug delivery. Adv Drug Deliv Rev 56:1529–31
160. Z.S.Pillai, P.V.Kamat. (2004). What factors control the size and shape of silver nanoparticles in the citrate ion reduction method? J Phys Chem B 108:945–51
161. V.Pokharkar, D.Bhumkar, K.Suresh,. (2011). Gold nanoparticles as a potential carrier for transmucosal vaccine delivery. J Biomed Nanotechnol 7:57–9
162. M.K.Rai, S.Deshmukh, A.P.Ingle, A.K.Gade. (2012). Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria. J Appl Microbiol 112:841–52
163. M.K.Rai, A.P.Yadav, A.K.Gade. (2009). Silver nanoparticles as a new generation of antimicrobials. Biotehnol Adv 27:76–83
164. C.N.R.Rao, G.U.Kulkarni, P.J.Thomas, P.Edwards. (2002). Size-dependent chemistry: properties of nanocrystals. Chem A Eur J 8:29–35
165. A.K.Reddy, B.J.Rathinaraj, P.Prathyusha,. (2011). Emerging trends of nanotechnology in cancer therapy. Int J Pharm Biol Arch 2:1–8
166. G.R.Reddy, M.S.Bhojani, P.McConville,. (2006). Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin Can Res 12:6677
167. D.G.Richards, D.L.McMIllin, E.A.Mein, C.D.Nelson. (2002). Gold and its relationship to neurological/glandular conditions. Int J Neurosci 112:31–53
168. R.Rossau, H.Traore, H.De Beenhouwer,. (1997). Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the simultaneous detection of Mycobacterium tuberculosis complex and its resistance to rifampicin. Antimicrob Agents Chemother 41:2093–8
169. T.Sadhukha, S.Prabha. (2014). Encapsulation in nanoparticles improves anti-cancer efficacy of carboplatin. AAPS Pharm Sci Tech 15:1029–38
170. C.A.D.Santos, M.M.Seckler, A.P.Ingle,. (2014). Silver nanoparticles: therapeutical uses, toxicity, and safety issues. J Pharm Sci 103:1931–44
171. J.Sarkar, D.Chattopadhyay, S.Patra,. (2011). Alternaria alternata mediated synthesis of protein capped silver nanoparticles and their genotoxic activity. Dig J Nanomater Biostruct 6:563–73
172. P.K.Sarkar, S.Das, P.K.Prajapati. (2010). Ancient concept of metal pharmacology based on ayurvedic literature. Anc Sci Life 29:1–6
173. T.K.Sau, A.Pal, N.R.Jana,. (2001). Size controlled synthesis of gold nanoparticles using photo-chemically prepared seed particles. J Nanopart Res 3:257–61
174. D.Seth, S.R.Choudhury, S.Pradhan,. (2011). Nature-inspired novel drug design paradigm using nanosilver: efficacy on multi-drug-resistant clinical isolates of tuberculosis. Curr Microbiol 62:715–26
175. A.Shakeri-Zadeh, S.Khoei, S.Khoee,. (2013). Targeted, monitored and controlled chemotherapy: a multimodal nanotechnology-based approach against cancer. ISRN Nanotechnol 2013: Article ID 629510, 5 pages
176. J.Sharifi-Rad, S.M.Hoseini-Alfatemi, M.Sharifi-Rad, M.Iriti. (2014). Antimicrobial synergic effect of allicin and silver nanoparticles on skin infection caused by methicillin-resistant Staphylococcus aureus spp. Ann Med Health Sci Res 4:863–8
177. X.Shi, S.Wang, S.Meshinchi,. (2007). Dendrimer entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging. Small 3:1245–52
178. S.K.Shinde, N.D.Grampurohit, D.D.Gaikwad,. (2012). Toxicity induced by nanoparticles. Asian Pac J Trop Dis 2:331–4
179. C.A.Sierra-Rivera, M.A.Franco-Molina, E.Mendoza-Gamboa,. (2013). Potential of colloidal or silver nanoparticles to reduce the growth of B16F10 melanoma tumors. Afr J Microbiol Res 7:2745–50
180. M.Singh, D.Movia, O.K.Mahfoud,. (2013). Silver nanowires as prospective carriers for drug delivery in cancer treatment: an in vitro biocompatibility study on lung adenocarcinoma cells and fibroblasts. Eur J Nanomed 5:195–204
181. P.C.Soo, Y.T.Horng, K.C.Chang,. (2009). A simple gold nanoparticle probes assay for identification of Mycobacterium tuberculosis and Mycobacterium tuberculosis complex from clinical specimens. Mol Cell Probes 23:240–6
182. R.W.Sun, D.L.Mav, E.L.Wong, C.M.Che. (2007). Some uses of transition metal complexes as anti-cancer and anti-HIV agents. Dalton Trans 43:4884–92
183. X.Sun, Z.Wang, S.Zhai,. (2013). In vitro cytotoxicity of silver nanoparticles in primary rat hepatic stellate cells. Mol Med Rep 8:1365–72
184. C.Svedman, K.Dunér, M.Kehler,. (2006). Lichenoid reactions to gold from dental restorations and exposure to gold through intracoronary implant of a gold-plated stent. Clin Res Cardiol 95:689–91
185. A.Taglietti, A.Yuri, D.Fernandez,. (2012). Antibacterial activity of glutathione-coated silver nanoparticles against gram positive and gram negative bacteria. Langmuir 28:8140–8
186. R.M.Taylor, T.C.Monson, R.R.Gullapalli. (2014). Influence of carbon chain length on the synthesis and yield of fatty amine-coated iron-platinum nanoparticles. Nanoscale Res Lett 9:306, doi: 10.1186/1556-276X-9-306
187. J.C.Tefry, D.P.Wooley. (2012). Rapid assessment of antiviral activity and cytotoxicity of silver nanoparticles using a novel application of the tetrazolium-based colorimetric assay. J Virol Methods 183:19–24
188. Y.Teow, S.Valiyaveettil. (2010). Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles. Nanoscale 2:2607–13
189. A.S.Thakor, S.S.Gambhir. (2013). Nano-oncology: the future of cancer diagnosis and therapy. CA: Cancer J Clin 63:395–418
190. C.Thiruppathiraja, S.Kamatchiammal, P.Adaikkappan,. (2011). Specific detection of Mycobacterium sp. genomic DNA using dual labeled gold nanoparticle based electrochemical biosensor. Anal Biochem 417:73–9
191. D.L.Thorek, A.Tsourkas. (2008). Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials 29:3583–90
192. E.Torres-Chavolla, E.C.Alocilja. (2011). Nanoparticle based DNA biosensor for tuberculosis detection using thermophilic helicase-dependent isothermal amplification. Biosens Bioelectron 26:4614–18
193. T.Ueno, K.Endo, K.Hori,. (2014). Assessment of antitumor activity and acute peripheral neuropathy of 1,2-diaminocyclohexane platinum (II)-incorporating micelles (NC-4016). Int J Nanomed 9:3005–12
194. R.K.Visaria, R.J.Griffin, B.W.Williams,. (2006). Enhancement of tumor thermal therapy using gold nanoparticle assisted tumor necrosis factor-A delivery. Mol Cancer Ther 5:1014–20
195. H.Wang, L.Zheng, R.Guo,. (2012). Dendrimer-entrapped gold nanoparticles as potential CT contrast agents for blood pool imaging. Nanoscale Res Lett 7:190, doi: 10.1186/1556-276X-7-190
196. 3 and ZnO nanoparticles. Nanotoxicology (early online) 2011:1–10
197. World Health Organization, Available from: http://www.who.int/mediacentre/news/releases/2014/amr-report/en/ (2014)
198. T.Xia, Y.Zhao, T.Sager,. (2011). Decreased dissolution of ZnO by iron doping yields nanoparticles with reduced toxicity in the rodent lung and zebrafish embryos. ACS Nano 5:1223–35
199. D.X.Xiang, Q.Chen, L.Pang, C.L.Zheng. (2011). Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro. J Virol Methods 178:137–42
200. Y.Yamagishi, A.Watari, Y.Hayata,. (2013a). Acute and chronic nephrotoxicity of platinum nanoparticles in mice. Nanoscale Res Lett 8:395, doi: 10.1186/1556-276X-8-395
201. Y.Yamagishi, A.Watari, Y.Hayata,. (2013b). Hepatotoxicity of sub-nanosized platinum particles in mice. Pharmazie 68:178–82
202. J.Yao, D.R.Larson, H.D.Vishwasrao,. (2005). Blinking and nonradiant dark fraction of water-soluble quantum dots in aqueous solution. Proc Natl Acad Sci USA 102:14284–9
203. M.S.Yavuz, Y.Cheng, J.Chen,. (2009). Gold nanocages covered by smart polymers for controlled release with near-infrared light. Nat Mater 8:935–9
204. M.V.Yezhelyev, X.Gao, Y.Xing,. (2006). Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol 7:657–67
205. Y.Yoshihisa, A.Honda, Q.Zhao,. (2010). Protective effects of platinum nanoparticles against UV-light-induced epidermal inflammation. Exp Dermatol 19:1000–6
206. L.Zhang, H.Deng, F.Lin,. (2014). In situ growth of porous platinum nanoparticles on graphene oxide for colorimetric detection of cancer cells. Anal Chem 86:2711–18
207. L.Zhang, L.Laung, W.Munchgesang,. (2010). Reducing stress on cells with apoferritin-encapsulated platinum nanoparticles. Nano Lett 10:219–23
208. S.X.Zhang, J.Gao, T.A.Buchholz,. (2009). Quantifying tumor-selective radiation dose enhancements using gold nanoparticles: a Monte Carlo simulation study. Biomed Microdevices 11:925–33
209. X.Zhang, J.Z.Xing, J.Chen,. (2008). Enhanced radiation sensitivity in prostate cancer by gold-nanoparticles. Clin Invest Med 31:E160–7
210. X.D.Zhang, D.Wu, X.Shen,. (2011). Size-dependent in vivo toxicity of PEG-coated gold nanoparticles. Int J Nanomed 6:2071–81
211. Y.J.Zhang, R.Huang, X.F.Zhu,. (2012). Synthesis, properties, and optical applications of noble metal nanoparticle-biomolecule conjugates. Mater Sci 57:238–46
212. L.Zheng, L.Jia, B.Li,. (2012). A sandwich HIV p24 amperometric immunosensor based on a direct gold electroplating-modified electrode. Molecules 17:5988–6000
213. X.Zhou, X.Zhang, X.Yua,. (2008). The effect of conjugation to gold nanoparticles on the ability of low molecular weight chitosan to transfer DNA vaccine. J Shen Biomater 29:111–17
214. Y.Zhou, Y.Kong, S.Kundu,. (2012). Antibacterial activities of gold and silver nanoparticles against Escherichia coli and Bacillus Calmette-Guerin. J Nanobiotechnol 10:19, doi: 10.1186/1477-3155-10-19